Results 101 to 110 of about 23,130 (165)

Density-adjusted analysis of cell interactions to decipher tissue landscape changes. [PDF]

iScience
Siddiqui M, Hamidinekoo A, Tan JY, Leke R, Zarrouki B, Trahearn N, Hagos YB, Sakr C, Lampis A, Bagnall C, Pellegrini G, Castillo SP, Challis B, Yuan Y, Bezzi M, Ling S.   +15 more
europepmc   +1 more source

Current Smoking and Pharmacological Treatment Responses in Chronic Obstructive Pulmonary Disease: Not Clear-Cut. [PDF]

Am J Respir Crit Care Med
Bardsley S, Fagerås M, Marshall J, Martin N, Psallidas I, Singh D.   +5 more
europepmc   +1 more source

Clinical outcomes and costs associated with viral lower respiratory tract disease hospitalisations. [PDF]

BMJ Open Respir Res
Maslova E, Fagerås M, Tran T, Emmanuel B, Khezrian M, Branscombe N, Johnson S, Dalal G, Syed HU, Yehya N.   +9 more
europepmc   +1 more source

Stochastic Gates for Covariate Selection in Population Pharmacokinetics Modeling. [PDF]

CPT Pharmacometrics Syst Pharmacol
Kekic M, Stepanov O, Wang W, Richardson S, Olabode D, Traynor C, Dearden R, Zhou D, Tang W, Gibbs M, Nowojewski A.   +10 more
europepmc   +1 more source

Plasma proteomics stratification identifies phospholamban R14del carriers at risk for disease progression. [PDF]

Cardiovasc Res
Deiman FE, Arslan T, de Brouwer R, Henry I, Löfgren L, Cavallin A, Michopoulos F, Nilsson R, Henricsson M, Ahlstrom C, Davidsson P, Bomer N, Grote Beverborg N, van der Meer P.   +13 more
europepmc   +1 more source

The Role of Microemulsions in Enhancing the Stability of Biopharmaceuticals. [PDF]

Drug Des Devel Ther
Yu X, Jing Y, Sun J, Jin M, Bai S, Zhu R, Zhang Y, Lu Y, Song JY, Ma Y.   +9 more
europepmc   +1 more source

DOMINICA protocol: A study of benralizumab for severe eosinophilic asthma in children. [PDF]

Pediatr Allergy Immunol
Guilbert TW, Jison M, Sjö LB, Werkström V, Grindebacke H, Durżyński T, Lal A, Grigg J.   +7 more
europepmc   +1 more source

Integrating transcriptomics and proteomics to assess antisense oligonucleotide safety and efficacy: a time-resolved approach. [PDF]

NAR Mol Med
van Leeuwen D, Cipullo M, Williams EC, Iannetta A, Chu B, Wang J, Hamza G, Crysnanto D, Guzzi N, Tan JY, Miele E, Sawarkar R, Mohorianu I, Prill S, Andersson P.   +14 more
europepmc   +1 more source

Real-world disease burden, patient journey and treatment patterns in eosinophilic granulomatosis with polyangiitis in Europe and the USA. [PDF]

EULAR Rheumatol Open
Spiera R, Dolin P, Ding B, Jain P, Westerink L, Edmonds C, Pennant T, Carter OT, Hennessy F, Chen SY.   +9 more
europepmc   +1 more source